Eli Lilly has filed six new U.S. lawsuits against sellers in the Eli Lilly retatrutide black market, adding to referrals covering more than 200 entities and 14,000 illegal listings. The drugmaker is calling on platforms and payment firms to help shut down the illegal trade.
Genentech and Roche have filed a new patent-infringement lawsuit against Biocon in New Jersey federal court, alleging Biocon’s proposed pertuzumab biosimilar infringes patents covering Perjeta, Roche’s blockbuster HER2-positive breast-cancer treatment, the second major U.S. action against Biocon over the same product in 2026.
Novo Nordisk has filed a federal lawsuit accusing Eli Lilly of running misleading Zepbound and Mounjaro ads that compare outdated, lower doses of Wegovy and Ozempic — omitting newer, FDA-approved higher-strength options.
Indian health officials have intercepted a shipment of suspected counterfeit weight-loss medication. The discovery of fake Mounjaro pens underscores a growing global trend of illicit medical supplies entering the market through online platforms like Alibaba.
In a significant legal victory, Novo Nordisk announced on December 31, 2025, that China’s Supreme People’s Court had issued a final, positive ruling upholding the [Read More…]
